Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Updated Phase I Study Results of PHE885, a T-Charge Manufactured BCMA-Directed CAR T-Cell Therapy, for Pts With R/R MM"

233 views
June 9, 2023
Comments 0
Login to view comments. Click here to Login